Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York